comparative effectiveness

Research in Review

PD-L1 Testing Uncommon Among NSCLC Patients on Immunotherapy

06/03/2017

JCP Editors

Few patients treated with immunotherapy for metastatic non–small cell lung cancer (NSCLC) at United States community practices receive appropriate programmed death-ligand 1 (PD-L1) expression testing, according to...

Few...

06/03/2017

Journal of Clinical Pathways

Real-World Data Shows Metastatic Bladder Cancer Survival Worse Than in Clinical Trials

05/31/2017

JCP Editors

Few patients with metastatic urothelial carcinoma of the bladder are surviving as long in the real-world as those in clinical trials, according to new research. Current overall survival projections for patients with...

Few...

05/31/2017

Journal of Clinical Pathways

Research in Review

Radiation Therapy Significantly Increases Survival in Type of B-Cell Malignancy

05/31/2017

JCP Editors

Patients with Hodgkin lymphoma who are treated with radiation therapy are more likely to survive the disease than those not treated with radiation therapy, according to a recent study published in Anticancer Research...

...

05/31/2017

Journal of Clinical Pathways

Research in Review

ASCT Deemed Safe and Effective for Older Patients With B-Cell Malignancies

05/25/2017

JCP Editors

Older patients with B-cell malignancies benefit from progression-free survival (PFS) and overall survival (OS) improvements after autologous stem cell transplantation (ASCT), according to research that will be...

Older...

05/25/2017

Journal of Clinical Pathways

Research in Review

Young Patients With Colorectal Cancer May Benefit From More Treatment Options

05/25/2017

JCP Editors

Patients aged 45 years or younger with colorectal cancer may have better treatment options available to them because of more mutations in their tumors than older patients, according to research that will be presented...

...

05/25/2017

Journal of Clinical Pathways

Research in Review

Cost-Effectiveness Analysis Reveals Optimal Screening Strategy for Prostate Cancer

05/23/2017

JCP Editors

A diagnostic magnetic resonance imaging (MRI) scan followed by an MRI-guided biopsy strategy is more cost-effective than an invasive transrectal ultrasound for detecting prostate cancer, according to research...

A...

05/23/2017

Journal of Clinical Pathways

Research in Review

Risk-Adapted Therapy Reduces Treatment Toxicity for Patients With Hodgkin Lymphoma

05/19/2017

JCP Editors

A combined chemotherapy approach may eliminate the toxic effects of radiation therapy in children and young adults with Hodgkin lymphoma, according to early results of a study that will be presented at the 2017 ASCO...

A...

05/19/2017

Journal of Clinical Pathways

Research in Review

Immune Checkpoint Inhibitors May Increase Response to CAR-T Therapy in ALL

05/19/2017

JCP Editors

Pembrolizumab improves response to chimeric antigen receptor (CAR) T-cell treatments in pediatric patients with B-cell relapsed acute lymphoblastic leukemia (ALL), according to research that will be presented at...

...

05/19/2017

Journal of Clinical Pathways

Research in Review

Chemotherapy After Surgery Improves Survival in Biliary Tract Cancer

05/18/2017

JCP Editors

Administering capecitabine after surgery extends survival by a median of 17 months compared with surgery alone for patients with biliary tract cancer, according to research that will be presented at the 2017 ASCO...

...

05/18/2017

Journal of Clinical Pathways

Research in Review

New Therapy May Effectively Treat Rare B-Cell Malignancy

05/18/2017

JCP Editors

A new treatment for a rare B-cell malignancy provided an objective response rate of 41% in a clinical trial, published in Blood (published online May 10, 2017; doi:10.1182/blood-2016-12-758383). ----- Related...

A new...

05/18/2017

Journal of Clinical Pathways